Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Initial Insomnia in Children With ADHD
NCT02333149Phase 3Withdrawn
- Sponsor
- University of Alberta
- Start
- Jan 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in Insomnia comparing Melatonin with Placebo (2 arms). Primary endpoint: Sleep Onset Latency at 6 weeks. Planned start Jan 2019; status: withdrawn.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02333149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333149.